Spectrum Brands Holdings faces structural concerns despite operational strengths, with sluggish revenue growth and declining sales in key divisions raising red flags for investors. Tariff impacts and ...
“You always have to make certain market assumptions,” Harbinger Capital Investments founder Phil Falcone said at Delivering Alpha in September 2011. “My assumptions are that mosquitoes will still bite ...
Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon (formerly eflapegrastim), a long-acting G-CSF for treating chemotherapy-induced neutropenia (CIN). The FDA's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback